A combination of cuproptosis and lncRNAs predicts the prognosis and tumor immune microenvironment in cervical cancer

被引:2
作者
Huang, Yitong [1 ]
Pan, Chenxiang [1 ]
Wu, Suni [1 ]
Ye, Feng [1 ]
Yang, Lihua [2 ]
机构
[1] Wenzhou Med Univ, Wenzhou Cent Hosp, Dingli Clin Inst, Dept Gynecol Oncol, Wenzhou 325000, Zhejiang, Peoples R China
[2] Tangshan Maternal & Child Hlth Hosp, Dept Gynecol, Tangshan 063000, Hebei, Peoples R China
关键词
LncRNAs; Cervical cancer; TME; Cuproptosis; Prognosis; PROGRESSION;
D O I
10.1007/s12672-024-00964-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Cuproptosis induces proteotoxic stress and eventually leads to cell death. However, the relationship between cuproptosis and lncRNAs in cervical cancer has not been fully elucidated. Therefore, we aim to explore the association among lncRNAs, cuproptosis and clinical features in cervical cancer.Methods RNA sequencing, genetic mutations, and clinical data of CESC patients were obtained from TCGA. Cuproptosis-associated genes were gathered. WGCNA was used to cluster important modules, and KEGG, GO, GSEA and GSVA were used to explore functional and pathway enrichment. The association between immune microenvironment and cuproptosis-related lncRNAs was performed by using cibersort algorithm and other platforms, including XCELL, TIMER, QUANTISEQ, MCPCOUNTER and EPIC. Fluorescence quantitative PCR was employed to detect the expression of LINC01833 and LINC02321, and CCK-8 and cell scratch assays were used to assess cell proliferation and migration capabilities after LINCRNA interference.Results 202 upregulated and 45 downregulated lncRNAs were selected. The survival analysis showed that there was a statistically significant difference in survival rates between the high-risk and low-risk groups. The prognosis of tumour mutation burden and the degree of immune infiltration were differed noticeably between the high-risk and low-risk groups. BHG712, TL-2-105, FR-180204, Masitinib, TAK-715, ODI-027, JW-7-24-2, and OSI-930 had substantially higher IC50 values in the high-risk group. Notably, we found AL360178.1 was associated with RNF44 E3 ubiquitin ligase expression. In cervical cancer cell lines, LINC01833 and LINC02321 displayed significant upregulation. Efficient siRNA transfection led to a decreased expression of LINC01833 and LINC02321. This knockdown significantly hindered both cell proliferation and migration capabilities in cervical cancer cells compared to the negative control.Conclusion In conclusion, we constructed five cuprotosis-related lncRNA prognostic models, which may be new tumor therapeutic targets for the prevention and treatment of cervical cancer.
引用
收藏
页数:23
相关论文
共 57 条
[31]   Construction and comprehensive analysis of a curoptosis-related lncRNA signature for predicting prognosis and immune response in cervical cancer [J].
Liu, Li ;
Zheng, Jianfeng ;
Xia, Hongmei ;
Wu, Qiaoling ;
Cai, Xintong ;
Ji, Liyan ;
Sun, Yang .
FRONTIERS IN GENETICS, 2023, 14
[32]   RETRACTED: MIR600HG sponges miR-125a-5p to regulate glycometabolism and cisplatin resistance of oral squamous cell carcinoma cells via mediating RNF44 (Retracted Article) [J].
Liu, Xingguang ;
Zhao, Tengda ;
Yuan, Zhe ;
Ge, Shaohua .
CELL DEATH DISCOVERY, 2022, 8 (01)
[33]   Signature of seven cuproptosis-related lncRNAs as a novel biomarker to predict prognosis and therapeutic response in cervical cancer [J].
Liu, Xinyu ;
Zhou, Lei ;
Gao, Minghui ;
Dong, Shuhong ;
Hu, Yanan ;
Hu, Chunjie .
FRONTIERS IN GENETICS, 2022, 13
[34]   RETRACTED: Overexpressed RING Finger 44 Correlates with Poor Prognosis in Hepatocellular Carcinoma (Retracted Article) [J].
Liu, Yue ;
Xia, Huasong ;
Li, Meng ;
Chen, Yuxin ;
Zhou, Wei ;
Chen, Yi ;
Wu, Yanqing .
JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
[35]   Advances in HPV Screening Tests for Cervical Cancer-A Review [J].
Lucksom, Pesona Grace ;
Sherpa, Mingma Lhamu ;
Pradhan, Anup ;
Lal, Sunaina ;
Gupta, Chamma .
JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA, 2022, 72 (01) :13-18
[36]   Long non-coding RNAs: definitions, functions, challenges and recommendations [J].
Mattick, John S. S. ;
Amaral, Paulo P. P. ;
Carninci, Piero ;
Carpenter, Susan ;
Chang, Howard Y. Y. ;
Chen, Ling-Ling ;
Chen, Runsheng ;
Dean, Caroline ;
Dinger, Marcel E. E. ;
Fitzgerald, Katherine A. A. ;
Gingeras, Thomas R. R. ;
Guttman, Mitchell ;
Hirose, Tetsuro ;
Huarte, Maite ;
Johnson, Rory ;
Kanduri, Chandrasekhar ;
Kapranov, Philipp ;
Lawrence, Jeanne B. B. ;
Lee, Jeannie T. T. ;
Mendell, Joshua T. T. ;
Mercer, Timothy R. R. ;
Moore, Kathryn J. J. ;
Nakagawa, Shinichi ;
Rinn, John L. L. ;
Spector, David L. L. ;
Ulitsky, Igor ;
Wan, Yue ;
Wilusz, Jeremy E. E. ;
Wu, Mian .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2023, 24 (06) :430-447
[37]   SPARCLE, a p53-induced lncRNA, controls apoptosis after genotoxic stress by promoting PARP-1 cleavage [J].
Meza-Sosa, Karla F. ;
Miao, Rui ;
Navarro, Francisco ;
Zhang, Zhibin ;
Zhang, Ying ;
Hu, Jun Jacob ;
Hartford, Corrine Corrina R. ;
Li, Xiao Ling ;
Pedraza-Alva, Gustavo ;
Perez-Martinez, Leonor ;
Lal, Ashish ;
Wu, Hao ;
Lieberman, Judy .
MOLECULAR CELL, 2022, 82 (04) :785-+
[38]   Patterns of Recurrent Disease in Cervical Cancer [J].
Micco, Maura ;
Lupinelli, Michela ;
Mangialardi, Matteo ;
Gui, Benedetta ;
Manfredi, Riccardo .
JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (05)
[39]   SnapShot: Types of Ubiquitin Ligases [J].
Morreale, Francesca Ester ;
Walden, Helen .
CELL, 2016, 165 (01) :248-+
[40]   Extracellular Matrix-Related Six-lncRNA Signature as a Novel Prognostic Biomarker for Bladder Cancer [J].
Qing, Liangliang ;
Gu, Peng ;
Liu, Mingsheng ;
Shen, Jihong ;
Liu, Xiaodong ;
Guang, Runyun ;
Ke, Kunbin ;
Huang, Zhuo ;
Lee, Wenhui ;
Zhao, Hui .
ONCOTARGETS AND THERAPY, 2020, 13 :12521-12538